A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Selexipag Glycine Adduct - Request Quote

Picture of Selexipag Glycine Adduct

Selexipag Glycine Adduct

SZ CAT No:SZ-S024015
CAS No
NA
Mol.F.
C27H32N4O4
Mol.Wt.
476.6
Inv. Status
In Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Selexipag Glycine Adduct is chemically (2-(4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)acetyl)glycine. Selexipag Glycine Adduct is supplied with detailed characterization data compliant with regulatory guideline. Selexipag Glycine Adduct can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Selexipag.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Selexipag Glycine Adduct

Purchase Selexipag Glycine Adduct

Selexipag Glycine Adduct suppliers

Selexipag Glycine Adduct manufacturers

Selexipag Glycine Adduct price

Order Selexipag Glycine Adduct

Enquire Selexipag Glycine Adduct

Selexipag Glycine Adduct cost

Selexipag Glycine Adduct Supplier

Selexipag Glycine Adduct Distributor

Selexipag Glycine Adduct for Method Validation

Selexipag Reference Standard

Selexipag Glycine Adduct for ANDA Filing

Selexipag Glycine Adduct for Forced Degradation Studies

Selexipag Glycine Adduct Identification Standards

Selexipag Glycine Adduct for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,